FORTH THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

5 employees website.com
Research and experimental development on biotechnology
F

FORTH THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 3 May 2024 Active London, England 5 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 21 Nov 2025 Next due 28 Feb 2027 8 months remaining
Confirmation Submitted 8 Jul 2025 Next due 16 May 2026 21 days overdue
Net assets £2M
Total assets £3M
Total Liabilities £480K
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Pancras Square C/O Sofinnova Partners London N1C 4AG England

Full company profile for FORTH THERAPEUTICS LIMITED (15702694), an active company based in London, England. Incorporated 3 May 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jun → 31 May 2025
Type total-exemption-full
Next accounts 31 May 2026
Due by 28 Feb 2027 8 months remaining

Net Assets, Total Assets & Total Liabilities (2025–2025)

Cash in Bank

£2.31M

Net Assets

£2.19M

Total Liabilities

£479.83k

Turnover

N/A

Employees

5

Debt Ratio

18%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 May Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Alexander Robert LeechDirectorBritishUnited Kingdom536 Aug 2024Active
Cristina PelizonDirectorItalianUnited Kingdom576 Aug 2024Active
Neil HendersonDirectorBritishUnited Kingdom523 May 2024Active

Shareholders

Shareholders (5)

Neil Henderson
40.6%
8,000
Sofinnova Biovelocita Ii Slp
38.9%
7,672

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Neil Henderson

British

Active
Notified 3 May 2024
Residence Scotland
DOB January 1974
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Prof Neil Henderson

British

Active
Notified 3 May 2024
Residence United Kingdom
DOB January 1974
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Nov 2025AccountsAnnual accounts made up to 31 May 2025
8 Jul 2025Persons With Significant ControlChange to Prof Neil Henderson as a person with significant control on 6 Aug 2024
8 Jul 2025Confirmation StatementConfirmation statement made on 2 May 2025 with updates
2 Jul 2025CapitalAllotment of shares (GBP 11.454) on 6 Aug 2024
2 Jul 2025CapitalAllotment of shares (GBP 19.701) on 6 Aug 2024
21 Nov 2025 Accounts

Annual accounts made up to 31 May 2025

8 Jul 2025 Persons With Significant Control

Change to Prof Neil Henderson as a person with significant control on 6 Aug 2024

8 Jul 2025 Confirmation Statement

Confirmation statement made on 2 May 2025 with updates

2 Jul 2025 Capital

Allotment of shares (GBP 11.454) on 6 Aug 2024

2 Jul 2025 Capital

Allotment of shares (GBP 19.701) on 6 Aug 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 May 2025

6 months ago on 21 Nov 2025

Change to Prof Neil Henderson as a person with significant control on 6 Aug 2024

11 months ago on 8 Jul 2025

Confirmation statement made on 2 May 2025 with updates

11 months ago on 8 Jul 2025

Allotment of shares (GBP 11.454) on 6 Aug 2024

11 months ago on 2 Jul 2025

Allotment of shares (GBP 19.701) on 6 Aug 2024

11 months ago on 2 Jul 2025